You have 9 free searches left this month | to do more

tgr-1202

Tgr 1202 is a drug used to treat Chronic Lymphocytic Leukemia, B-cell Non Hodgkin Lymphoma, CLL, and other conditions. Tgr 1202 is being actively studied in 6 studies and prior, has been studied in 3.

Top SponsorsTop SitesTop Investigators
TG Therapeutics, Inc.TG Therapeutics Investigational Trial SiteMatthew S. Davids, MD
Columbia UniversityTG Therapeutics Trial SiteMichael Savona
Dana-Farber Cancer InstituteBeth Israel Deaconness Medical Center
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
C
Terminated
  • Hodgkin Disease
  • Lymphoma, Non-hodgkin
  • New York, New York
    Columbia University Irving Medical Center - Center for Lymphoid
2021-06-28
Jun 28, 2021
C
Terminated
  • Follicular Lymphoma
  • TGR-1202
  • New York, New York
    Columbia University Medical Center
2021-06-28
Jun 28, 2021
U
Recruiting
  • CLL
  • B-cell Non Hodgkin Lymphoma
  • New Haven, Connecticut
  • +2 more
2021-01-05
Jan 5, 2021
V
Active, not recruiting
  • Myelofibrosis
  • Polycythemia Vera
  • Phoenix, Arizona
  • +4 more
2021-03-11
Mar 11, 2021
T
Enrolling by invitation
  • Chronic Lymphocytic Leukemia
  • Non Hodgkin Lymphoma
  • TGR-1202
  • TGR-1202 + Ublituximab
  • Huntsville, Alabama
  • +16 more
2021-11-11
Nov 11, 2021
D
Active, not recruiting
  • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  • Mantle Cell Lymphoma
  • Monterey, California
  • +5 more
2021-09-06
Sep 6, 2021
T
Completed
  • Chronic Lymphocytic Leukemia
  • TGR-1202
  • Huntsville, Alabama
  • +14 more
2021-10-14
Oct 14, 2021
T
Completed
  • Non-Hodgkin's Lymphoma
  • +3 more
  • TGR-1202
  • Sarasota, Florida
  • +6 more
2021-08-20
Aug 20, 2021
T
Completed
  • Pancreatic Cancer
  • +5 more
  • TGR-1202
  • +3 more
  • Nashville, Tennessee
    TG Therapeutics Trial Site
2019-10-01
Oct 1, 2019
T
Enrolling by invitation
  • Chronic Lymphocytic Leukemia
  • ublituximab
  • TGR-1202
  • Huntsville, Alabama
  • +85 more
2021-11-11
Nov 11, 2021
T
Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Obinutuzumab
  • +3 more
  • Huntsville, Alabama
  • +153 more
2021-11-11
Nov 11, 2021